Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)

被引:0
|
作者
Ladwa, R. [1 ]
Pattison, D. [2 ]
Smith, J. [2 ]
Goodman, S. [2 ]
Burge, M. [3 ]
Rose, S. [4 ]
Dowson, N. [4 ]
Wyld, D. [3 ]
机构
[1] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Canc Care Serv, Brisbane, Qld, Australia
[4] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
关键词
68ga-dotatate pet-ct; suv parameters; tumor response; somatostatin receptor tumor volume;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
K11
引用
收藏
页码:249 / 249
页数:1
相关论文
共 2 条
  • [1] Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors
    Vandecaveye, Vincent
    Dresen, Raphaela C.
    Pauwels, Elin
    Van Binnebeek, Sofie
    Vanslembrouck, Ragna
    Baete, Kristof
    Mottaghy, Felix M.
    Clement, Paul M.
    Nackaerts, Kristiaan
    Van Cutsem, Eric
    Verslype, Chris
    De Keyzer, Frederik
    Deroose, Christophe M.
    RADIOLOGY-IMAGING CANCER, 2022, 4 (03):
  • [2] Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
    Weikert, Thomas
    Maas, Ole Christopher
    Haas, Tanja
    Klarhofer, Markus
    Bremerich, Jens
    Forrer, Flavio
    Sauter, Alexander Walter
    Sommer, Gregor
    CONTRAST MEDIA & MOLECULAR IMAGING, 2019, 2019